Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2-inhibitors versus other glucose-lowering agents in real-world clinical practice: Results from the CVD-REAL study



Kosiborod, Mikhail, Birkeland, Kare I, Cavender, Matthew A, Fu, Alex Z, Wilding, John P ORCID: 0000-0003-2839-8404, Khunti, Kamlesh, Holl, Reinhard W, Norhammar, Anna, Jorgensen, Marit E, Wittbrodt, Eric T
et al (show 5 more authors) (2018) Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2-inhibitors versus other glucose-lowering agents in real-world clinical practice: Results from the CVD-REAL study. DIABETES OBESITY & METABOLISM, 20 (8). 1983 - 1987.

[img] Text
Kosiborod CVD-REAL AMI and STROKE_DOM_resubmitted.docx - Accepted Version

Download (391kB)
Item Type: Article
Uncontrolled Keywords: cardiovascular disease, observational study, SGLT2 inhibitor, type 2 diabetes
Depositing User: Symplectic Admin
Date Deposited: 13 Apr 2018 10:17
Last Modified: 11 Jun 2021 13:10
DOI: 10.1111/dom.13299
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3020121